Medical Communications

Showing 15 posts of 6402 posts found.

s_world_pills

Global manufacturing harmonisation: Towards a worldwide safety network

July 2, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing compliance, feature, manufacturing, manufacturing compliance, pharma

Manufacturing of pharmaceuticals takes place all over the world and the health of patients globally is at stake. Ben Hargreaves …

Novartis spins off Alcon as CEO focuses drug search

June 29, 2018 Medical Communications, Sales and Marketing Alcon, Novartis, eye care, pharma

Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.Novartis has …

Pfizer’s Xeljanz scores EU approval for active psoriatic arthritis

June 29, 2018 Medical Communications, Sales and Marketing EU, Europe, Pfizer, Xeljanz, pharma, psoriatic arthritis

Pfizer has announced that the European Commission (EC) has approved Xeljanz in combination with methotrexate (MTX) for the treatment of …

NICE turns down Roche’s Ocrevus in early primary progressive multiple sclerosis

June 29, 2018 Medical Communications, Sales and Marketing NICE, Ocrevus, Roche, pharma

Roche’s sometimes strained relationship with NICE continues as the health watchdog for England and Wales chose to reject the former’s …
amazon

Amazon makes first move into healthcare with online pharmacy acquisition

June 28, 2018 Medical Communications, Sales and Marketing amazon, pharma, pharmacy

It’s been thought to have been on the cards for some time, but now, after much speculation, retail giant Amazon …
s_electronic_medical_record

Centralised EMR systems drive patient-physician relationships, report indicates

June 28, 2018 Medical Communications, Research and Development Electronic Medical Records, pharma

Advancement of IT within healthcare is transforming the dynamics of the patient-physician relationship and it is important to integrate various …
save_our_nhs

NHS “below average” in treating eight most common causes of death, report says

June 26, 2018 Manufacturing and Production, Medical Communications NHS, pharma

The NHS’s 70th birthday is again marked as a bittersweet one as a new report from the Nuffield Trust highlights …
si_lem_new_photo_171118

Working Life: Vertex Pharma’s Simon Lem, VP, Regional General Manager of North Europe

June 25, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, Vertex pahrma, Working Life, feature, pharma

Pharmafocus caught up with Vertex Pharma’s Simon Lem to discuss his journey throughout the industry and the importance of the …
sandi_peterson

J&J’s second-in-command to retire, alongside executive restructure

June 25, 2018 Medical Communications, Sales and Marketing J&J, JJ, Johnson & Johnson, pharma

Johnson & Johnson’s Group Worldwide Chairman Sandra Peterson (pictured) has announced she is to retire from her role and the …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

The sun is out in the UK, it’s Friday, and the July/August issue of Pharmafocus is going to print. And, …

NICE backs Sanofi’s new treatment for atopic dermatitis

June 22, 2018 Medical Communications, Sales and Marketing England, NICE, Sanofi, UK, atopic dermatitis, pharma

NICE has published a positive Final Appraisal Determination FAD recommending dupilumab, in combination with topical corticosteroids, for use on the …
fda2outsideweb

FDA approves first continuous glucose monitoring system

June 22, 2018 Medical Communications, Sales and Marketing FDA, diabetes, pharma

The US Food and Drug Administration (FDA) has approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people …
astrazeneca_sign_sky

AstraZeneca’s Imfinzi becomes India’s first available immunotherapy for lung cancer

June 22, 2018 Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, India, NSCLC, lung cancer, pharma

In a big step forward for India as AstraZeneca announces that its checkpoint inhibitor Imfinzi (durvalumab) has secured approval in …
roche__tree

Roche’s Ocrevus cleared for NHS use in relapsing-remitting MS

June 22, 2018 Medical Communications, Sales and Marketing MS, NICE, UK, multiple sclerosis, pharma

Roche and multiple sclerosis (MS) patients across England and Wales are celebrating the news that healthcare watchdog NICE has recommended …
The Gateway to Local Adoption Series

Latest content